A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial (SAPS)
SAPS:Smoking Asthmatics Pilot Study:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT01696214, this PHASE4 trial focuses on Asthma and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2019 — Feb 2019 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Nov 2018 — Jan 2019 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .